Curr Cardiol Rep . Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

[tetano]

Curr Cardiol Rep


. 2020 Jun 11;22(7):52.
doi: 10.1007/s11886-020-01327-9.
Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment


Madan Raj Aryal ¹ , Rohit Gosain ² , Anthony Donato ³ , Ranjan Pathak ⁴ , Vijaya Raj Bhatt ⁵ , Anjan Katel ⁶ , Peter Kouides ⁷



Affiliations

• PMID: 32529517
• DOI: 10.1007/s11886-020-01327-9

Abstract

Purpose of review: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients.
Recent findings: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients. Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.

Keywords: COVID-19; Deep vein thrombosis; Extended prophylaxis; Pulmonary embolism; Thromboprophylaxis; Venous thromboembolism.